Innovative RNA-based therapeutics for serious disease. Thalia Therapeutics is a biotechnology company developing innovative RNA-based therapeutics and delivery technologies in oncology and cardiovascular disease. We are focused on unlocking the full therapeutic potential of RNA by overcoming the fundamental challenges of delivery, enabling targeted, scalable and clinically meaningful medicines for patients with significant unmet medical needs. Specialising in RNA, RNA Delivery, oncology, and cardiovascular disease. Reformulating medicines to improve claims and performance. Focus on drug solubility and vaccine improvement